Educational content about cannabinoid science, not medical advice. Consult a healthcare professional before combining CBD products with medication. Our age policy
CBG and CBD: Two Cannabinoids, One Hemp Plant

Definition
CBG and CBD come from the same plant, but never in the same quantity. In the plant's chemistry, CBGA sits at the front of the pathway and CBDA arrives on a branch further along. By the time hemp is mature, CBD is the abundant fraction and CBG is under one percent.
One plant, two very different yields
Cut a mature hemp plant and there is plenty of CBD in it. Look in the same plant for CBG and you are usually under one percent. Same field, same botany, two completely different quantities. That gap explains most of what separates the two oils on the shelf, including what they cost to produce. It helps to have a few points straight before any label comparison makes sense.
- Chemically, both compounds begin at the same address. The 1998 work of Fellermeier described a hemp transferase enzyme attaching a prenyl group to olivetolate, which yields cannabigerolic acid, better known as CBGA [1].
- That same paper identified CBGA as the precursor of tetrahydrocannabinol [1]. The front of the pathway feeds several things, not one.
- From that single precursor, the route branches. One of those branches leads to cannabidiolic acid, CBDA, which is the acid form of CBD [1].
- So the order inside the plant is CBGA first, CBDA afterwards. CBG belongs to the early stage. CBD is what the plant keeps accumulating.
- By harvest, most of the early compound has already been converted. Under one percent of the plant means CBG has to be gathered from a small remainder rather than taken from a stockpile.
- Both sit inside a large family of plant compounds. The 2005 review by ElSohly catalogued the chemical constituents of the plant, cannabinoids included [2].
- Research on both starts from the same place too: the endocannabinoid system, the receptor system that cannabinoid research took as its starting point. Evidence for individual cannabinoids is at different stages, and CBG has been studied far less than CBD.
Scarcity as a line item
Price differences between cannabinoid oils usually trace back to plant chemistry rather than positioning. Here the reason is measurable. CBD is what a mature hemp plant has piled up. CBG is what remains of the compound that came first.
| What is being compared | CBD | CBG |
|---|---|---|
| Position in the plant's pathway | Arrives later, via CBDA, on a branch from the shared precursor [1] | Sits at the front, as CBGA, the precursor itself [1] |
| Share of a mature harvest | The rich fraction of the plant | Under 1% of the plant |
| Starting material for extraction | Drawn from what the plant has stockpiled | Gathered from a small remainder |
| Consequence for cost | Abundance keeps the input side straightforward | Scarcity is the cost driver |
| Described in 1998 | The same pathway paper follows other branches onward [1] | CBGA named as the precursor of THC [1] |
| Place in the wider family | Both appear in the 2005 catalogue of the plant's chemical constituents [2] | |
Read the table downwards and the pattern is consistent. Nothing here is about one cannabinoid being finer than the other. It is about how much of each a plant hands over at the end of a season, and how much work sits behind the milligrams that reach a bottle. Abundance made CBD the first cannabinoid the category learned to talk about. Scarcity is why CBG arrived on shelves years later, and why it is still the smaller half of most catalogues, ours included.
Label against label, in milligrams
The two Cibdol bottles are written in different units, which is where confusion usually starts. One states a percentage. The other states milligrams for two compounds. Same 10ml bottle underneath.
| On the label | Cibdol CBD oil | Cibdol CBG oil |
|---|---|---|
| Bottle size | 10ml | 10ml |
| Front-of-label figure | A percentage, from 5% to 40% | Two milligram figures |
| What that figure is | A proportion of the oil, not a total | The content of the bottle, stated directly |
| CBG content | Not part of this formula | 500mg |
| CBD content | 500mg at 5%, 4000mg at 40% | 250mg |
| Ratio | One cannabinoid | 2:1, CBG to CBD |
| Total cannabinoid per bottle | 500mg at 5%, across one compound | 750mg, across two compounds |
| Formula options | Eight concentration steps, 5% to 40% | One formula |
| THC on the batch certificate | Within legal limits, published per batch | 0.000% |
The row that does the most work is the total. A 5% CBD oil and the CBG oil both mention the figure 500mg, and they mean different things by it. In one bottle that is the whole cannabinoid content. In the other it is the larger of two entries. If you want to compare the two honestly, compare bottle totals and compound counts, not the numbers printed largest.
The maths behind the front number
Five percent of ten millilitres
On a CBD oil, the percentage is a proportion of the oil in the bottle. It is not a total, and it means nothing without the bottle size beside it. Our CBD oils run from 5% to 40%, always in 10ml. Do the arithmetic once and it stops feeling abstract. Ten millilitres at 5% works out at 500mg of CBD. The same 10ml at 40% holds 4000mg. Between those two, the oil itself, the format and the pipette are unchanged. Only the proportion of CBD moves. Ten millilitres is the constant across the whole range, so the percentage carries all the information.
Two compounds, one total
The CBG oil states its contents in milligrams instead: 500mg CBG and 250mg CBD in the same 10ml bottle. That is a 2:1 ratio and 750mg of cannabinoid in total, spread across two compounds rather than one. Set it next to the 5% CBD oil and the difference is clear enough. Five hundred milligrams in total, one compound, versus 750mg in total, two compounds. The coincidence in that first figure catches people out regularly. Same number, different molecule, and in the CBG bottle there are another 250mg of CBD listed underneath it. Label against label is the only comparison that holds.
Which bottle ends up in the basket
The abundant side of the plant
CBD oil is the uncomplicated shelf. The cannabinoid is the one a mature harvest gives up in quantity, the bottle format does not vary, and the decision in front of you is a concentration between 5% and 40%. One cannabinoid, one choice. A higher percentage is a specification, not a recommendation, because all it changes is how many milligrams sit inside the 10ml. Pick the concentration that makes the amount you prefer straightforward to take, then leave the number alone.
The scarcer side
The CBG oil comes from the under-one-percent end of the plant, and there is one formula rather than a range: 500mg CBG with 250mg CBD. Worth noticing that CBG is named alongside CBD on that label, not instead of it. Both compounds are printed, both are batch-tested, and the certificate lists THC at 0.000%, so nothing in the bottle is intoxicating. Since 2014 we have kept to one discipline here: publish what is in the bottle, per batch, so the label can be read and checked before anyone buys it rather than afterwards. Two cannabinoids from one plant, both accounted for in milligrams.
Frequently Asked Questions
4 questionsDoes Cibdol CBG oil contain any THC?
How many milligrams of CBD are in a 5% oil?
What makes CBG harder to obtain than CBD?
What does the 2:1 ratio on the CBG oil label mean?
About this article
Luke Sholl has been writing about cannabinoids, CBD, and the broader benefits of nature since 2011. His background includes first-hand cannabis cultivation experience spanning the full seed-to-harvest lifecycle across so
This wiki article was drafted with AI assistance and reviewed by Luke Sholl, CBD & wellness writer. Editorial oversight by Joshua Askew.
Medical disclaimer. This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before use of any substance.
Last reviewed August 26, 2026
References (2)
- [1]Fellermeier, M. and Zenk, M.H. (1998). Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol. DOI: https://doi.org/10.1016/s0014-5793(98)00450-5
- [2]ElSohly, M.A. and Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. DOI: https://doi.org/10.1016/j.lfs.2005.09.011
Related Articles

Does CBG Make You Sleepy? What's Actually on Record
The idea that cannabigerol brings on drowsiness is widely repeated, but the 2021 review by Nachnani and Barrett describes receptor sites rather than sensations in volunteers. The same thing happened to CBN, and Corroon traced it in 2021.

THCA vs THC: A Single Carboxyl Group Apart
One carboxyl group separates the acid form found in the plant from the neutral compound most people talk about. Here is what happens when it goes, and why two lab figures from one plant are not a contradiction.

Broad Spectrum CBD: What The Term Covers
Broad spectrum sits between full spectrum and isolate, and it's the one name on that list with no legal definition behind it. Here's what the term commits to, what research covers, and what our own range holds.

THCP: A Cannabinoid With Two Extra Carbons
Tetrahydrocannabiphorol turned up in an Italian medicinal cannabis variety in December 2019, in work led by Cinzia Citti [1]. Here is what that report actually records, and where our own range sits.

CBD Research: What the Human Data Covers
A calm look at what has actually been measured in cannabidiol studies, where the published record thins out, and what to check before you believe a claim.

Serotonin, 5-HT and the One Cannabinoid Link on Record
5-HT is not one receptor but at least seven families of them, each split into subtypes. Here is what that means for reading claims, and what the 2005 in vitro report on cannabidiol at 5-HT1a does and does not cover [1].

PEA and Anandamide: A Family Resemblance in Chemistry
Palmitoylethanolamide shares a chemical class and a clearance route with anandamide. Here is what that family resemblance settles, and what it deliberately leaves open.

The Endocannabinoid System in Six Papers, 1964 to 1995
The structure of THC was published in 1964, the first cannabinoid receptor in 1990, anandamide in 1992. Six reports, thirty-one years, and a name that runs backwards.

2016: What Clinical Endocannabinoid Deficiency (CECD) Actually Means
CECD is a testable idea about underactive endocannabinoid signalling, set out most clearly in a 2016 paper by Russo [1]. Here is what that paper names, and where the record stops.

